Secondly, SLC6A19 plays a significant role in ccRCC and presents intimately correlation with fatty acid metabolism alongside with CPT1A, which is extensively considered as a tumor suppressor of ccRCC. Here, SLC6A19 is linked to nonpapillary renal cell carcinoma.